Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 26, 2022, 6:08 p.m.

/zigman2/quotes/200043077/composite

$

34.00

Change

+0.75 +2.26%

Volume

Volume 7,402

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Today's close

$ 33.73

$ 33.25

Change

-0.48 -1.42%

Day low

Day high

$33.03

$36.14

Open

52 week low

52 week high

$30.25

$79.70

Open

Vicki L. Sato

Dr. Vicki L. Sato is an Independent Director at Akouos, Inc., a Non-Executive Chairman at Vir Biotechnology, Inc., a Non-Executive Chairman at Denali Therapeutics, Inc., a Member-Overseers Board at The Isabella Stewart Gardner Museum, Inc. and a Venture Partner at ARCH Venture Partners LLC. She is on the Board of Directors at Allogene Therapeutics, Inc., Akouos, Inc., Peer Health Exchange and Prize4Life, Inc. Dr. Sato was previously employed as an Independent Director by BorgWarner, Inc., an Independent Director by Syros Pharmaceuticals, Inc., an Independent Non-Executive Director by Galapagos NV, a Lead Independent Director by Bristol Myers Squibb Co., a Professor by Harvard Business School, a Professor by Harvard University, an Independent Director by PerkinElmer, Inc. (United States), a President by Vertex Pharmaceuticals, Inc., a Vice President-Research by Biogen Idec, Inc., a Business Advisor by Atlas Venture, Inc., an Advisor by BioVentures Investors, a Trustee by José Mateo Ballet Theatre, and a Member-Scientific Counselors Board by The Broad Institute, Inc. She also served on the board at Proclara Biosciences, Inc., Alnylam Pharmaceuticals, Inc., Avila Therapeutics, Inc., Infinity Pharmaceuticals, Inc. and Nimbus Therapeutics LLC. She received her undergraduate degree from Harvard University, an undergraduate degree from Radcliffe College and a doctorate degree from Harvard University.

Transactions

Date Shares Transaction Value
11/10/2021 660   Disposition at $53.3 per share. 35,178
11/10/2021 1,006   Disposition at $52.49 per share. 52,805
11/01/2021 1,666   Disposition at $50.05 per share. 83,384
09/15/2021 140   Disposition at $54.76 per share. 7,667
09/15/2021 620   Disposition at $53.92 per share. 33,431
09/15/2021 676   Disposition at $53.03 per share. 35,849
09/15/2021 230   Disposition at $52.28 per share. 12,025
08/18/2021 860   Disposition at $52.12 per share. 44,824
08/18/2021 806   Disposition at $51.26 per share. 41,316
07/21/2021 400   Disposition at $65.78 per share. 26,312
07/21/2021 866   Disposition at $65.24 per share. 56,498
07/21/2021 400   Disposition at $64.25 per share. 25,700
06/23/2021 986   Disposition at $71.1 per share. 70,105
06/23/2021 680   Disposition at $70.2 per share. 47,736
06/02/2021 2,074   Award at $0 per share. 0
05/26/2021 40   Disposition at $66.72 per share. 2,669
05/26/2021 732   Disposition at $65.88 per share. 48,225
05/26/2021 894   Disposition at $64.9 per share. 58,021
04/28/2021 688   Disposition at $63.03 per share. 43,365
04/28/2021 597   Disposition at $62.05 per share. 37,044
04/28/2021 381   Disposition at $60.71 per share. 23,131
03/31/2021 136   Disposition at $57.61 per share. 7,835
03/31/2021 635   Disposition at $56.92 per share. 36,145
03/31/2021 877   Disposition at $55.91 per share. 49,034
03/31/2021 18   Disposition at $54.38 per share. 979
03/03/2021 115   Disposition at $63.36 per share. 7,287
03/03/2021 266   Disposition at $62.29 per share. 16,570
03/03/2021 1,050   Disposition at $61.52 per share. 64,596
03/03/2021 235   Disposition at $60.36 per share. 14,185
12/12/2017 62,500   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Chief Operating Officer & Secretary
Mr. Steve E. Krognes
Treasurer, Chief Financial & Accounting Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Trending Tickers
  • /zigman2/quotes/207732364/composite MSFT-2.66%
  • /zigman2/quotes/203165245/composite T+0.53%
  • /zigman2/quotes/213120645/composite DKNG-3.54%
  • /zigman2/quotes/209901640/composite SPY-1.22%
  • /zigman2/quotes/209958550/composite AUPH+3.30%
X
Powered by StockTwits
Link to MarketWatch's Slice.